Explore /
Poster
/ Impact of complete molecular response (CMR) on survival in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

Impact of complete molecular response (CMR) on survival in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

Authors

Nicholas James Short

The University of Texas MD Anderson Cancer Center, Houston, TX

Nicholas James Short , Elias Jabbour , Jorge E. Cortes , Rebecca Garris , Susan Mary O'Brien , Keyur Patel , Koji Sasaki , Ghayas C. Issa , Guillermo Garcia-Manero , Deborah A. Thomas , Hagop M. Kantarjian , Farhad Ravandi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Acute Leukemia

Citation

J Clin Oncol 34, 2016 (suppl; abstr 7034)

DOI

10.1200/JCO.2016.34.15_suppl.7034

Abstract #

7034

Poster Bd #

Abstract Disclosures

Similar Posters

Poster

2019 ASCO Annual Meeting

Allogeneic hematopoietic stem cell transplantation contributes to eradication of minimal residual disease in adult Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with dasatinib.

First Author: Jeremy Chang

Poster

2018 ASCO Annual Meeting

$Outcomes with inotuzumab ozogamicin (InO) in patients with Philadelphia chromosome–positive (Ph+) relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).$